Claris Law Legal Blogging Community

Recent Entries

RSS 2.0 feed Add to My Yahoo!
Add to Bloglines Add to your My Feedster
Add to your NewsGator My MSN
Ortho Evra Attorney

Ortho Evra Stroke Information

editor photo

Editor: Robert Blanchard
Profession: Attorney at Law

January 09, 2006

By Tom Young

TrackBack (0)

Category: Ortho Evra Medical Information

Physicians and attorneys are researching the birth control patch more closely after health officials revealed that the product may lead to an increased risk of stroke in women who use it as their primary means of birth control. Attorneys began investigating the patch in 2004, when an othersie healthy 18-year-old New York fashion student died while using the Ortho Evra patch. A pulmonary embolism, or blood clot had reportedly moved into her lung. Nearly 20 fatalities have been linked to the patch since its introduction.

A stroke occurs in a persons brain, and is caused by loss of oxegyn to brain tissues. A stroke is usually the result of a blood clot or ruptured blood vessel in the brain and can cause severe injuries or death. Stroke symptoms include, but are not limited to, partial paralysis, memory loss, pain, loss of cognitive functions. If you or someone you know has suffered any of these stroke symptoms, regardless of using the Ortho Evra birth control patch, seek medical help immediately.

Ortho Evra, introduced in November 2001, releases hormones, including a large amount of estrogen, into the blood stream to prevent pregnancy. According to reports obtained by watchdog groups and organizations such as the U.S. Food and Drug Administration, the patch has been linked to dozens of strokes, heart attacks and blood clots, some involving fatalities. Over 4 million women have used the patch since its introduction.

If you have suffered a stroke while using the Ortho Evra patch, a lawyer is waiting to speak to you. Fill out our online form for a free evaluation by an experienced Ortho Evra stroke attorney.

Trackback Pings

TrackBack URL for this entry:
http://myblog.clarislaw.com/cgi-bin/usa/mt-tb.cgi/8

Email Article



(optional):